Answers are grounded in this paper and cite their sources.
The concept of the X inactivation center (Xic) as the master regulatory locus for X inactivation dates back to the mid-1960s (1, 2), not long after X chromosome inactivation itself was proposed as the mammalian dosage compensation mechanism (3–5). Defined genetically as the cis-acting locus required for an X chromosome to undergo inactivation early in female embryogenesis, the Xic defied molecular characterization for nearly 30 years until the discovery of the XIST gene (6), whose noncoding RNA product is transcribed from and remains intimately associated with the inactive X chromosome in female somatic cells (6–9). Xist in both humans and mice maps to the Xic region on the X chromosome and thus became a compelling candidate for a component of the Xic itself (10–12). Biology is rarely as simple as it first appears, however, and X inactivation embodies this principle fully! Only a few years ago, Lee and colleagues (13) described another component of the Xic just downstream of Xist, the Tsix gene, so-named because it consists of an antisense transcript of Xist and whose pattern of expression suggested a potential role as a regulator of Xist. Now, in this issue of PNAS, Stavropoulos et al. (14) extend these studies to address a fundamental question concerning the potential function of Tsix—does its antagonistic relationship to Xist depend on its own noncoding RNA product or does it reflect actions at the DNA level, independent of transcription?
No takes yet. Share an insight, caveat, or question.
Willard et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: